Browse
Search
Agenda - 06-01-2021; 6-a - Opioid Litigation Memorandum of Agreement
OrangeCountyNC
>
Board of County Commissioners
>
BOCC Agendas
>
2020's
>
2021
>
Agenda - 06-01-2021 Virtual Business Meeting
>
Agenda - 06-01-2021; 6-a - Opioid Litigation Memorandum of Agreement
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/27/2021 11:50:05 AM
Creation date
5/27/2021 12:00:19 PM
Metadata
Fields
Template:
BOCC
Date
6/1/2021
Meeting Type
Business
Document Type
Agenda
Agenda Item
6-a
Document Relationships
RES-2021-036-RESOLUTION Opioid Litigation Memorandum of agreement
(Message)
Path:
\Board of County Commissioners\Resolutions\2020-2029\2021
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
44
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
29 <br /> 3. Training and education regarding naloxone and other drugs that treat overdoses for first <br /> responders, overdose patients, patients taking opioids, families, schools, community support <br /> groups, and other members of the general public. <br /> 4. Enable school nurses and other school staff to respond to opioid overdoses, and provide them <br /> with naloxone, training, and support. <br /> 5. Expand, improve, or develop data tracking software and applications for overdoses/naloxone <br /> revivals. <br /> 6. Public education relating to emergency responses to overdoses. <br /> 7. Public education relating to immunity and Good Samaritan laws. <br /> 8.Educate first responders regarding the existence and operation of immunity and Good Samaritan <br /> laws. <br /> 9. Syringe service programs and other evidence-informed programs to reduce harms associated <br /> with intravenous drug use, including supplies, staffing, space, peer support services, referrals to <br /> treatment, fentanyl checking, connections to care, and the full range of harm reduction and <br /> treatment services provided by these programs. <br /> 10. Expand access to testing and treatment for infectious diseases such as HIV and Hepatitis C <br /> resulting from intravenous opioid use. <br /> 11. Support mobile units that offer or provide referrals to harm reduction services, treatment, <br /> recovery supports,health care, or other appropriate services to persons that use opioids or persons <br /> with OUD and any co-occurring SUD/MH conditions. <br /> 12. Provide training in harm reduction strategies to health care providers, students, peer recovery <br /> coaches,recovery outreach specialists, or other professionals that provide care to persons who use <br /> opioids or persons with OUD and any co-occurring SUD/MH conditions. <br /> 13. Support screening for fentanyl in routine clinical toxicology testing. <br /> PART THREE: OTHER STRATEGIES <br /> L FIRST RESPONDERS <br /> In addition to items in sections C, D, and H of this Exhibit relating to first responders, support the <br /> following: <br /> 1. Educate law enforcement or other first responders regarding appropriate practices and <br /> precautions when dealing with fentanyl or other drugs. <br /> 2. Provision of wellness and support services for first responders and others who experience <br /> secondary trauma associated with opioid-related emergency events. <br /> Exhibits,page 11 <br />
The URL can be used to link to this page
Your browser does not support the video tag.